Iqvia Holdings Inc Stock Nyse
Equities
US74876Y1010
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 15.49B | Sales 2025 * | 16.58B | Capitalization | 41.37B |
---|---|---|---|---|---|
Net income 2024 * | 1.34B | Net income 2025 * | 1.58B | EV / Sales 2024 * | 3.43 x |
Net Debt 2024 * | 11.83B | Net Debt 2025 * | 11.7B | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
31
x | P/E ratio 2025 * |
25.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.84% |
Latest transcript on Iqvia Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 20-07-31 |
James Berkshire
COO | Chief Operating Officer | 51 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 16-10-02 |
Colleen Goggins
BRD | Director/Board Member | 68 | 17-07-26 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
1st Jan change | Capi. | |
---|---|---|
+20.63% | 46.81B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.66% | 26.06B | |
-19.61% | 19.13B | |
+32.10% | 12.39B | |
+0.19% | 12.08B | |
-0.41% | 11.96B | |
+19.86% | 11.56B |